Sign In

Login

Password

Forgot Password ? Sign Up

Prostatakrebs (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prostatakrebs" in German language version.

refsWebsite
Global rank German rank
70nih.gov
4th place
7th place
60doi.org
2nd place
3rd place
8zdb-katalog.de
123rd place
6th place
5web.archive.org
1st place
1st place
3krebsdaten.de
low place
5,533rd place
3leitlinienprogramm-onkologie.de
low place
9,990th place
2cancer.org
3,680th place
low place
2krebsinformationsdienst.de
low place
4,592nd place
2sciencedirect.com
149th place
298th place
2auajournals.org
low place
low place
2wcrf.org
low place
low place
2aerzteblatt.de
3,043rd place
200th place
2krebshilfe.de
low place
2,196th place
2igel-monitor.de
low place
3,916th place
2aacrjournals.org
8,869th place
5,334th place
2prostatakrebs-bps.de
low place
low place
2awmf.org
5,401st place
312th place
1iarc.fr
4,025th place
4,508th place
1ccrcal.org
low place
low place
1healthline.com
3,733rd place
8,532nd place
1acc.org
low place
3,617th place
1cancer.gov
1,684th place
7,111th place
1lebenmitkrebs.ch
low place
low place
1brca-netzwerk.de
low place
low place
1laborkrone.de
low place
low place
1ladr.de
low place
low place
1krebsgesellschaft.de
low place
5,865th place
1medizin-transparent.at
low place
2,661st place
1degro.org
low place
low place
1praxis-margareten.at
low place
low place
1urologielehrbuch.de
low place
3,838th place
1helios-gesundheit.de
low place
8,042nd place
1aerztezeitung.de
low place
711th place
1uni-luebeck.de
low place
6,860th place
1orf.at
418th place
22nd place
1kup.at
low place
2,918th place
1akdae.de
low place
1,853rd place
1europa.eu
68th place
29th place
1swr.de
1,755th place
114th place
1iqwig.de
low place
3,381st place
1uroweb.org
low place
low place

aacrjournals.org (Global: 8,869th place; German: 5,334th place)

cancerpreventionresearch.aacrjournals.org

cancerres.aacrjournals.org

acc.org (Global: low place; German: 3,617th place)

aerzteblatt.de (Global: 3,043rd place; German: 200th place)

aerztezeitung.de (Global: low place; German: 711th place)

akdae.de (Global: low place; German: 1,853rd place)

auajournals.org (Global: low place; German: low place)

  • Stacy Loeb, Benjamin C. Fu, Scott R. Bauer, Claire H. Pernar, June M. Chan: Mp32-06 association of plant-based dietary patterns with prostate cancer risk. In: Journal of Urology. Band 206, Supplement 3, 1. September 2021, S. e566–e567, doi:10.1097/JU.0000000000002036.06 (auajournals.org [abgerufen am 25. September 2021]).
  • Natasha Gupta, Jacob Taylor, James Borin, Kenneth Jacobsohn, Stacey Kenfield: Pd03-04 systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. In: Journal of Urology. Band 207, Supplement 5, 1. Mai 2022, S. e42, doi:10.1097/JU.0000000000002518.04 (auajournals.org [abgerufen am 21. Mai 2022]).

awmf.org (Global: 5,401st place; German: 312th place)

register.awmf.org

awmf.org

brca-netzwerk.de (Global: low place; German: low place)

cancer.gov (Global: 1,684th place; German: 7,111th place)

cancer.org (Global: 3,680th place; German: low place)

ccrcal.org (Global: low place; German: low place)

degro.org (Global: low place; German: low place)

doi.org (Global: 2nd place; German: 3rd place)

  • K. J. Bell, C. Del Mar, G. Wright, J. Dickinson, P. Glasziou: Prevalence of incidental prostate cancer: A systematic review of autopsy studies. In: International Journal of Cancer. Band 137, Nummer 7, Oktober 2015, S. 1749–1757, doi:10.1002/ijc.29538. PMID 25821151, PMC 4682465 (freier Volltext) (Review).
  • J. L. Jahn, E. L. Giovannucci, M. J. Stampfer: The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. In: International Journal of Cancer, Dezember 2015, Band 137, Nummer 12, S. 2795–2802, doi:10.1002/ijc.29408. PMID 25557753, PMC 4485977 (freier Volltext) (Review).
  • A. F. Olumi: Commentary on „integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.“; Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.: Cancer Cell 23(2), 2013, S. 159–70. In: Urologic oncology. Band 32, Nummer 2, Februar 2014, S. 212, doi:10.1016/j.urolonc.2013.08.018. PMID 24445294.
  • T. Matsuda, K. Saika: Comparison of time trends in prostate cancer incidence (1973–1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV VIII. In: Japanese journal of clinical oncology. Band 37, Nummer 7, Juli 2007, S. 556–557, doi:10.1093/jjco/hym100. PMID 17720742.
  • G. G. Giles et al.: Sexual factors and prostate cancer. In: BJU International. 92, 2003, S. 211–216. PMID 12887469. doi:10.1046/j.1464-410X.2003.04319.x
  • Jennifer R. Rider et al.: Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. In: European Urology. Band 70, Nr. 6, 1. Dezember 2016, S. 974–982, doi:10.1016/j.eururo.2016.03.027, PMID 27033442.
  • Gary G. Schwartz, Carol L. Hanchette: UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States). In: Cancer Causes & Control. Band 17, Nr. 8, Oktober 2006, S. 1091–1101, doi:10.1007/s10552-006-0050-6 (englisch).
  • Minu M. Ali, V. Vaidya: Vitamin D and cancer. In: Journal of Cancer Research and Therapeutics. Band 3, Nr. 4, Oktober 2007, S. 225–230, doi:10.4103/0973-1482.38998, PMID 18270398 (englisch).
  • H. Glossmann: Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose? In: Gerontology. Band 57, Nummer 4, 2011, S. 350–353, doi:10.1159/000322521. PMID 21196703. (Review).
  • Goran Bjelakovic et al.: Vitamin D supplementation for prevention of cancer in adults. In: The Cochrane Database of Systematic Reviews. Nr. 6, 23. Juni 2014, S. CD007469, doi:10.1002/14651858.CD007469.pub2, PMID 24953955 (englisch).
  • Philippe Autier et al.: Vitamin D status and ill health: a systematic review. In: The Lancet Diabetes & Endocrinology. Band 2, Nr. 1, 1. Januar 2014, S. 76–89, doi:10.1016/S2213-8587(13)70165-7 (englisch).
  • G. Markozannes et al.: Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence. In: Eur J Cancer. Band 69, 2016, S. 61–69, doi:10.1016/j.ejca.2016.09.026, PMID 27816833 (sciencedirect.com [PDF]).
  • Stacy Loeb, Benjamin C. Fu, Scott R. Bauer, Claire H. Pernar, June M. Chan: Mp32-06 association of plant-based dietary patterns with prostate cancer risk. In: Journal of Urology. Band 206, Supplement 3, 1. September 2021, S. e566–e567, doi:10.1097/JU.0000000000002036.06 (auajournals.org [abgerufen am 25. September 2021]).
  • Natasha Gupta, Jacob Taylor, James Borin, Kenneth Jacobsohn, Stacey Kenfield: Pd03-04 systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. In: Journal of Urology. Band 207, Supplement 5, 1. Mai 2022, S. e42, doi:10.1097/JU.0000000000002518.04 (auajournals.org [abgerufen am 21. Mai 2022]).
  • Kathryn M. Wilson et al.: Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression. In: Eur J Cancer. Band 9, Nr. 12, 2016, S. 933–941, doi:10.1158/1940-6207.CAPR-16-0070, PMID 27651069 (aacrjournals.org [PDF]).
  • L. C. Bylsma, D. D. Alexander: A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer. In: Nutr J. 2015, 21, 14, S. 933–941, doi:10.1186/s12937-015-0111-3. PMID 26689289, PMC 4687294 (freier Volltext)
  • K. Wu et al.: Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. In: Int J Cancer. Band 138, Nr. 10, 2016, S. 2368–2382, doi:10.1002/ijc.29973, PMID 26685908, PMC 4837898 (freier Volltext).
  • Walter C. Willett, David S. Ludwig: Milk and Health. In: New England Journal of Medicine. Band 382, Nr. 7, 13. Februar 2020, ISSN 0028-4793, S. 644–654, doi:10.1056/NEJMra1903547, PMID 32053300.
  • A. Sargsyan, H. B. Dubasi: Milk Consumption and Prostate Cancer: A Systematic Review. In: World J Mens Health. 2020 Jul 27. doi:10.5534/wjmh.200051. PMID 32777868.
  • Kazuya Mikami, Kotaro Ozasa, Tsuneharu Miki, Yoshiyuki Watanabe, Mitsuru Mori: Dairy products and the risk of developing prostate cancer: A large-scale cohort study (JACC Study) in Japan. In: Cancer Medicine. 4. Oktober 2021, ISSN 2045-7634, doi:10.1002/cam4.4233, PMID 34606688.
  • Catherine C. Applegate, Joe L. Rowles, Katherine M. Ranard, Sookyoung Jeon, John W. Erdman: Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. In: Nutrients. Band 10, Nr. 1, 4. Januar 2018, ISSN 2072-6643, doi:10.3390/nu10010040, PMID 29300347, PMC 5793268 (freier Volltext): „This hypothesis has further been supported by four previous meta-analyses of epidemiological studies, all of which showed a protective association between soy consumption and PCa …“
  • Catherine C. Applegate, Joe L. Rowles, Katherine M. Ranard, Sookyoung Jeon, John W. Erdman: Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. In: Nutrients. Band 10, Nr. 1, 4. Januar 2018, ISSN 2072-6643, doi:10.3390/nu10010040, PMID 29300347, PMC 5793268 (freier Volltext).
  • Thierry Capiod et al.: Do dietary calcium and vitamin D matter in men with prostate cancer? In: Nature Reviews Urology. Band 15, Nr. 7, Juli 2018, S. 453–461, doi:10.1038/s41585-018-0015-z.
  • Jutta Hübner et al.: Komplementärmedizin in der Uroonkologie. In: Der Urologe. Band 60, Nr. 7, 1. Juli 2021, S. 953–962, doi:10.1007/s00120-021-01584-8.
  • A. J. Pantuck et al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. In: Prostate Cancer and Prostatic Disease, 2015, 18, S. 242, doi:10.1038/pcan.2015.32.
  • A. van Bokhoven et al.: Molecular characterization of human prostate carcinoma cell lines. In: The Prostate. Band 57, Nummer 3, November 2003, S. 205–225, doi:10.1002/pros.10290. PMID 14518029.
  • A. B. Apolo, N. Pandit-Taskar, M. J. Morris: Novel tracers and their development for the imaging of metastatic prostate cancer. In: Journal of nuclear medicine. Band 49, Nummer 12, Dezember 2008, S. 2031–2041, doi:10.2967/jnumed.108.050658. PMID 18997047. (Review).
  • Bernhard Scher et al.: Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. In: European Journal of Nuclear Medicine and Molecular Imaging. Band 34, Nr. 1, Januar 2007, S. 45–53, doi:10.1007/s00259-006-0190-7, PMID 16932935.
  • M. A. Bjurlin, S. S. Taneja: Standards for prostate biopsy. In: Current opinion in urology. Band 24, Nummer 2, März 2014, S. 155–161, doi:10.1097/MOU.0000000000000031. PMID 24451092, PMC 4142196 (freier Volltext) (Review).
  • M. Brock, C. von Bodman, J. Palisaar, W. Becker, P. Martin-Seidel, J. Noldus: Detecting Prostate Cancer. In: Deutsches Ärzteblatt international. Band 112, Nummer 37, September 2015, S. 605–611, doi:10.3238/arztebl.2015.0605. PMID 26396046, PMC 4581108 (freier Volltext), deutsche Version: Detektion des Prostatakarzinoms, PDF.
  • A. M. Hoogland, C. F. Kweldam, G. J. van Leenders: Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. In: BioMed research international. Band 2014, S. 341324, doi:10.1155/2014/341324. PMID 25243131, PMC 4163394 (freier Volltext) (Review).
  • F. C. Hamdy et al.: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nummer 15, 10 2016, S. 1415–1424, doi:10.1056/NEJMoa1606220. PMID 27626136.
  • Jenny L. Donovan, Freddie C. Hamdy, J. Athene Lane, Malcolm Mason, Chris Metcalfe: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nr. 15, 13. Oktober 2016, S. 1425–1437, doi:10.1056/NEJMoa1606221, PMID 27626365, PMC 5134995 (freier Volltext).
  • P. Grimm et al.: Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. In: BJU international. Band 109, Supplement 1, Februar 2012, S. 22–29. doi:10.1111/j.1464-410X.2011.10827.x. PMID 22239226. (Review). praxis-margareten.at (PDF, Volltext)
  • H. Keller, J. Lehmann, J. Beier: Radical perineal prostatectomy and simultaneous extended pelvic lymph node dissection via the same incision. In: European urology. Band 52, Nummer 2, August 2007, S. 384–388, doi:10.1016/j.eururo.2006.09.045. PMID 17084507.
  • E. Sacco, T. Prayer-Galetti, F. Pinto, S. Fracalanza, G. Betto, F. Pagano, W. Artibani: Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up. In: BJU international. Band 97, Nummer 6, Juni 2006, S. 1234–1241, doi:10.1111/j.1464-410X.2006.06185.x. PMID 16686718.
  • Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, Malcolm Mason, Chris Metcalfe: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nr. 15, 13. Oktober 2016, ISSN 1533-4406, S. 1415–1424, doi:10.1056/NEJMoa1606220, PMID 27626136.
  • J. L. Donovan, F. C. Hamdy, J. A. Lane, M. Mason, C. Metcalfe: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. In: The New England journal of medicine. Band 375, Nr. 15, 13. Oktober 2016, ISSN 0028-4793, S. 1425–1437, doi:10.1056/NEJMoa1606221, PMID 27626365, PMC 5134995 (freier Volltext).
  • C. M. Yablon et al.: Complications of prostate cancer treatment: spectrum of imaging findings. In: Radiographics. Band 24, Supplement 1, Oktober 2004, S. S181–S194. doi:10.1148/rg.24si045502. PMID 15486240. (Review).
  • R. S. Kushwaha et al.: Physiologic changes of the anorectum after pelvic radiotherapy for the treatment of prostate and bladder cancer. In: Diseases of the Colon and Rectum. Band 46, Nummer 9, September 2003, S. 1182–1188, doi:10.1007/s10350-004-6712-0. PMID 12972961.
  • D. E. Spratt et al.: Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. In: Int J Radiat Oncol Biol Phys. 85(3), 1. März 2013, S. 686–692. doi:10.1016/j.ijrobp.2012.05.023. Epub 2012 Jul 12.
  • N. P. Mendenhall et al.: Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. In: International journal of radiation oncology, biology, physics. Band 88, Nummer 3, März 2014, S. 596–602, doi:10.1016/j.ijrobp.2013.11.007. PMID 24521677.
  • Großstudie PREFERE bewertet Therapien. In: Aktuel Urol. 44(02), 2013, S. 105, doi:10.1055/s-0033-1343926
  • P. J. Prada et al.: Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients. In: Brachytherapy. Band 8, Nr. 2, 2009, S. 210–217. doi:10.1016/j.brachy.2008.11.010. PMID 19213607.
  • W. R. Noyes, C. C. Hosford, S. E. Schultz: Human collagen injections to reduce rectal dose during radiotherapy. In: Int. J. Radiat. Oncol. Biol. Phys. Band 82, Nr. 5, April 2012, S. 1918–1922. doi:10.1016/j.ijrobp.2011.02.034. PMID 21514738
  • D. Y. Song et al.: A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. In: International journal of radiation oncology, biology, physics. Band 87, Nummer 1, September 2013, S. 81–87, doi:10.1016/j.ijrobp.2012.12.019. PMID 23414766. PMC 3737267 (freier Volltext).
  • M. Pinkawa et al.: Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. In: Radiotherapy and Oncology. Band 100, Nr. 3, September 2011, S. 436–441. doi:10.1016/j.radonc.2011.09.005. PMID 21963289.
  • M. J. Zelefsky et al.: Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. In: Int. J. Radiat. Oncol. Biol. Phys. Band 71, Nr. 4, July 2008, S. 1028–1033. doi:10.1016/j.ijrobp.2007.11.066. PMID 18280056.
  • M. Ritter, J. Forman, P. Kupelian, C. Lawton, D. Petereit: Hypofractionation for prostate cancer. In: Cancer J. Band 15, Nr. 1, 2009, S. 1–6. doi:10.1097/PPO.0b013e3181976614. PMC 3039916 (freier Volltext). PMID 19197165.
  • D. Margel et al.: Cardiovascular morbidity in a randomized trial comparing GnRH-agonist and GnRH-antagonist among patients with advanced prostate-cancer and pre-existing cardiovascular disease. In: American Urological Association (Hrsg.): The Journal of Urology. Elsevier-Verlag, 2019, doi:10.1097/JU.0000000000000384.
  • P. C. Albertsen et al.: Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. In: European Association of Urology (Hrsg.): European Urology. Band 65, Nr. 3. Elsevier-Verlag, 2014, S. 565–573, doi:10.1016/j.eururo.2013.10.032.
  • Grace L. Lu-Yao et al.: Survival following primary androgen deprivation therapy among men with localized prostate cancer. In: JAMA. Band 300, Nr. 2, 9. Juli 2008, S. 173–181, doi:10.1001/jama.300.2.173, PMID 18612114, PMC 2645653 (freier Volltext).
  • Ian F. Tannock et al.: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. In: The New England Journal of Medicine. Band 351, Nr. 15, 7. Oktober 2004, S. 1502–1512, doi:10.1056/NEJMoa040720, PMID 15470213.
  • C. J. Sweeney et al.: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. In: N Engl J Med. Band 373, 2015, S. 737–746. doi:10.1056/NEJMoa1503747
  • D. Mukherji, C. J. Pezaro, J. S. De-Bono: MDV3100 for the treatment of prostate cancer. In: Expert Opinion on Investigational Drugs. Band 21, Nummer 2, Februar 2012, S. 227–233, doi:10.1517/13543784.2012.651125. PMID 22229405.
  • L. Weissbach, J. Altwein: Aktive Überwachung oder aktive Therapie beim lokalen Prostatakarzinom? In: Deutsches Ärzteblatt international. Band 106, Nummer 22, Mai 2009, S. 371–376, doi:10.3238/arztebl.2009.0371. PMID 19623304. PMC 2704359 (freier Volltext). (Review).
  • G. Bozzini et al.: Focal therapy of prostate cancer: energies and procedures. In: Urologic oncology. Band 31, Nummer 2, Februar 2013, S. 155–167, doi:10.1016/j.urolonc.2012.05.011. PMID 22795500. (Review).
  • C. R. Porter et al.: 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. In: The Journal of urology. Band 176, Nummer 2, August 2006, S. 569–574, doi:10.1016/j.juro.2006.03.094. PMID 16813891.
  • Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L. J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Liisa Määttänen, Hans Lilja, Louis J. Denis, Franz Recker, Alvaro Paez, Chris H. Bangma, Sigrid Carlsson, Donella Puliti, Arnauld Villers, Xavier Rebillard, Matti Hakama, Ulf-Hakan Stenman, Paula Kujala, Kimmo Taari, Gunnar Aus, Andreas Huber, Theo H. van der Kwast, Ron H. N. van Schaik, Harry J. de Koning, Sue M. Moss, Anssi Auvinen, ERSPC Investigators: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. In: The Lancet. Band 384, Nr. 9959, 6. Dezember 2014, ISSN 1474-547X, S. 2027–2035, doi:10.1016/S0140-6736(14)60525-0, PMID 25108889, PMC 4427906 (freier Volltext).
  • Jonas Hugosson, u. a.: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. In: European Urology. Band 76, Nr. 1, 1. Juli 2019, ISSN 0302-2838, S. 43–51, doi:10.1016/j.eururo.2019.02.009, PMID 30824296, PMC 7513694 (freier Volltext) – (sciencedirect.com [abgerufen am 23. Oktober 2023]).

europa.eu (Global: 68th place; German: 29th place)

ema.europa.eu

healthline.com (Global: 3,733rd place; German: 8,532nd place)

helios-gesundheit.de (Global: low place; German: 8,042nd place)

iarc.fr (Global: 4,025th place; German: 4,508th place)

globocan.iarc.fr

igel-monitor.de (Global: low place; German: 3,916th place)

iqwig.de (Global: low place; German: 3,381st place)

krebsdaten.de (Global: low place; German: 5,533rd place)

krebsgesellschaft.de (Global: low place; German: 5,865th place)

krebshilfe.de (Global: low place; German: 2,196th place)

krebsinformationsdienst.de (Global: low place; German: 4,592nd place)

kup.at (Global: low place; German: 2,918th place)

laborkrone.de (Global: low place; German: low place)

ladr.de (Global: low place; German: low place)

lebenmitkrebs.ch (Global: low place; German: low place)

leitlinienprogramm-onkologie.de (Global: low place; German: 9,990th place)

medizin-transparent.at (Global: low place; German: 2,661st place)

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • K. J. Bell, C. Del Mar, G. Wright, J. Dickinson, P. Glasziou: Prevalence of incidental prostate cancer: A systematic review of autopsy studies. In: International Journal of Cancer. Band 137, Nummer 7, Oktober 2015, S. 1749–1757, doi:10.1002/ijc.29538. PMID 25821151, PMC 4682465 (freier Volltext) (Review).
  • J. L. Jahn, E. L. Giovannucci, M. J. Stampfer: The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. In: International Journal of Cancer, Dezember 2015, Band 137, Nummer 12, S. 2795–2802, doi:10.1002/ijc.29408. PMID 25557753, PMC 4485977 (freier Volltext) (Review).
  • G. D. Steinberg et al.: Family history and the risk of prostate cancer. In: The Prostate. Band 17, Nummer 4, 1990, S. 337–347. PMID 2251225.
  • A. F. Olumi: Commentary on „integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.“; Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.: Cancer Cell 23(2), 2013, S. 159–70. In: Urologic oncology. Band 32, Nummer 2, Februar 2014, S. 212, doi:10.1016/j.urolonc.2013.08.018. PMID 24445294.
  • N. Breslow et al.: Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. In: International Journal of Cancer. Band 20, Nummer 5, November 1977, S. 680–688. PMID 924691.
  • T. Matsuda, K. Saika: Comparison of time trends in prostate cancer incidence (1973–1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV VIII. In: Japanese journal of clinical oncology. Band 37, Nummer 7, Juli 2007, S. 556–557, doi:10.1093/jjco/hym100. PMID 17720742.
  • S. E. Berkow et al.: Diet and survival after prostate cancer diagnosis. In: Nutrition reviews. Band 65, Nummer 9, September 2007, S. 391–403. PMID 17958206. (Review).
  • M. A. Khan, A. W. Partin: Vasectomy and prostate cancer. In: Reviews in urology. Band 6, Nummer 1, 2004, S. 46–47. PMID 16985574. PMC 1472683 (freier Volltext).
  • G. G. Giles et al.: Sexual factors and prostate cancer. In: BJU International. 92, 2003, S. 211–216. PMID 12887469. doi:10.1046/j.1464-410X.2003.04319.x
  • Jennifer R. Rider et al.: Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. In: European Urology. Band 70, Nr. 6, 1. Dezember 2016, S. 974–982, doi:10.1016/j.eururo.2016.03.027, PMID 27033442.
  • Minu M. Ali, V. Vaidya: Vitamin D and cancer. In: Journal of Cancer Research and Therapeutics. Band 3, Nr. 4, Oktober 2007, S. 225–230, doi:10.4103/0973-1482.38998, PMID 18270398 (englisch).
  • H. Glossmann: Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose? In: Gerontology. Band 57, Nummer 4, 2011, S. 350–353, doi:10.1159/000322521. PMID 21196703. (Review).
  • Goran Bjelakovic et al.: Vitamin D supplementation for prevention of cancer in adults. In: The Cochrane Database of Systematic Reviews. Nr. 6, 23. Juni 2014, S. CD007469, doi:10.1002/14651858.CD007469.pub2, PMID 24953955 (englisch).
  • G. Markozannes et al.: Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence. In: Eur J Cancer. Band 69, 2016, S. 61–69, doi:10.1016/j.ejca.2016.09.026, PMID 27816833 (sciencedirect.com [PDF]).
  • L. N. Kolonel: Fat, meat, and prostate cancer. In: Epidemiologic reviews. Band 23, Nummer 1, 2001, S. 72–81. PMID 11588857. (Review).
  • D. S. Michaud et al.: A prospective study on intake of animal products and risk of prostate cancer. In: Cancer Causes & Control. Band 12, Nummer 6, August 2001, S. 557–567. PMID 11519764.
  • E. Giovannucci et al.: A prospective study of dietary fat and risk of prostate cancer. In: Journal of the National Cancer Institute. Band 85, Nummer 19, Oktober 1993, S. 1571–1579. PMID 8105097.
  • Kathryn M. Wilson et al.: Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression. In: Eur J Cancer. Band 9, Nr. 12, 2016, S. 933–941, doi:10.1158/1940-6207.CAPR-16-0070, PMID 27651069 (aacrjournals.org [PDF]).
  • L. C. Bylsma, D. D. Alexander: A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer. In: Nutr J. 2015, 21, 14, S. 933–941, doi:10.1186/s12937-015-0111-3. PMID 26689289, PMC 4687294 (freier Volltext)
  • K. Wu et al.: Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. In: Int J Cancer. Band 138, Nr. 10, 2016, S. 2368–2382, doi:10.1002/ijc.29973, PMID 26685908, PMC 4837898 (freier Volltext).
  • Walter C. Willett, David S. Ludwig: Milk and Health. In: New England Journal of Medicine. Band 382, Nr. 7, 13. Februar 2020, ISSN 0028-4793, S. 644–654, doi:10.1056/NEJMra1903547, PMID 32053300.
  • A. Sargsyan, H. B. Dubasi: Milk Consumption and Prostate Cancer: A Systematic Review. In: World J Mens Health. 2020 Jul 27. doi:10.5534/wjmh.200051. PMID 32777868.
  • Kazuya Mikami, Kotaro Ozasa, Tsuneharu Miki, Yoshiyuki Watanabe, Mitsuru Mori: Dairy products and the risk of developing prostate cancer: A large-scale cohort study (JACC Study) in Japan. In: Cancer Medicine. 4. Oktober 2021, ISSN 2045-7634, doi:10.1002/cam4.4233, PMID 34606688.
  • Catherine C. Applegate, Joe L. Rowles, Katherine M. Ranard, Sookyoung Jeon, John W. Erdman: Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. In: Nutrients. Band 10, Nr. 1, 4. Januar 2018, ISSN 2072-6643, doi:10.3390/nu10010040, PMID 29300347, PMC 5793268 (freier Volltext): „This hypothesis has further been supported by four previous meta-analyses of epidemiological studies, all of which showed a protective association between soy consumption and PCa …“
  • Catherine C. Applegate, Joe L. Rowles, Katherine M. Ranard, Sookyoung Jeon, John W. Erdman: Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. In: Nutrients. Band 10, Nr. 1, 4. Januar 2018, ISSN 2072-6643, doi:10.3390/nu10010040, PMID 29300347, PMC 5793268 (freier Volltext).
  • A. van Bokhoven et al.: Molecular characterization of human prostate carcinoma cell lines. In: The Prostate. Band 57, Nummer 3, November 2003, S. 205–225, doi:10.1002/pros.10290. PMID 14518029.
  • A. B. Apolo, N. Pandit-Taskar, M. J. Morris: Novel tracers and their development for the imaging of metastatic prostate cancer. In: Journal of nuclear medicine. Band 49, Nummer 12, Dezember 2008, S. 2031–2041, doi:10.2967/jnumed.108.050658. PMID 18997047. (Review).
  • M. D. Krahn et al.: Screening for prostate cancer. A decision analytic view. In: JAMA. 272(10), 1994, S. 773–780. PMID 7521400.
  • Bernhard Scher et al.: Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. In: European Journal of Nuclear Medicine and Molecular Imaging. Band 34, Nr. 1, Januar 2007, S. 45–53, doi:10.1007/s00259-006-0190-7, PMID 16932935.
  • Sven N. Reske et al.: Imaging prostate cancer with 11C-choline PET/CT. In: Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. Band 47, Nr. 8, August 2006, S. 1249–1254, PMID 16883001.
  • M. A. Bjurlin, S. S. Taneja: Standards for prostate biopsy. In: Current opinion in urology. Band 24, Nummer 2, März 2014, S. 155–161, doi:10.1097/MOU.0000000000000031. PMID 24451092, PMC 4142196 (freier Volltext) (Review).
  • M. Brock, C. von Bodman, J. Palisaar, W. Becker, P. Martin-Seidel, J. Noldus: Detecting Prostate Cancer. In: Deutsches Ärzteblatt international. Band 112, Nummer 37, September 2015, S. 605–611, doi:10.3238/arztebl.2015.0605. PMID 26396046, PMC 4581108 (freier Volltext), deutsche Version: Detektion des Prostatakarzinoms, PDF.
  • A. M. Hoogland, C. F. Kweldam, G. J. van Leenders: Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. In: BioMed research international. Band 2014, S. 341324, doi:10.1155/2014/341324. PMID 25243131, PMC 4163394 (freier Volltext) (Review).
  • H. Y. Wu, H. M. Snyder: Pediatric urologic oncology: bladder, prostate, testis. In: Urol Clin North Am. 31(3), 2004, S. 619–627, xi. PMID 15313070.
  • D. B. Groff: Pelvic neoplasms in children. In: J Surg Oncol. 77(1), 2001, S. 65–71. PMID 11344486.
  • F. K. Mostofi, C. J. Davis, I. A. Sesterhenn: Pathology of carcinoma of the prostate. In: Cancer, Juli 1992, Band 70, Nummer 1, Supplement, S. 235–253. PMID 1376194. (Review).
  • F. C. Hamdy et al.: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nummer 15, 10 2016, S. 1415–1424, doi:10.1056/NEJMoa1606220. PMID 27626136.
  • Jenny L. Donovan, Freddie C. Hamdy, J. Athene Lane, Malcolm Mason, Chris Metcalfe: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nr. 15, 13. Oktober 2016, S. 1425–1437, doi:10.1056/NEJMoa1606221, PMID 27626365, PMC 5134995 (freier Volltext).
  • P. Grimm et al.: Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. In: BJU international. Band 109, Supplement 1, Februar 2012, S. 22–29. doi:10.1111/j.1464-410X.2011.10827.x. PMID 22239226. (Review). praxis-margareten.at (PDF, Volltext)
  • H. Keller, J. Lehmann, J. Beier: Radical perineal prostatectomy and simultaneous extended pelvic lymph node dissection via the same incision. In: European urology. Band 52, Nummer 2, August 2007, S. 384–388, doi:10.1016/j.eururo.2006.09.045. PMID 17084507.
  • P. J. Davidson, D. van den Ouden, F. H. Schroeder: Radical prostatectomy: prospective assessment of mortality and morbidity. In: European urology. Band 29, Nummer 2, 1996, S. 168–173. PMID 8647142.
  • Brian McGlynn et al.: Management of urinary incontinence following radical prostatectomy. In: Urologic Nursing. Band 24, Nr. 6, Dezember 2004, S. 475–482, 515, PMID 15658733.
  • E. Sacco, T. Prayer-Galetti, F. Pinto, S. Fracalanza, G. Betto, F. Pagano, W. Artibani: Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up. In: BJU international. Band 97, Nummer 6, Juni 2006, S. 1234–1241, doi:10.1111/j.1464-410X.2006.06185.x. PMID 16686718.
  • Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, Malcolm Mason, Chris Metcalfe: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nr. 15, 13. Oktober 2016, ISSN 1533-4406, S. 1415–1424, doi:10.1056/NEJMoa1606220, PMID 27626136.
  • J. L. Donovan, F. C. Hamdy, J. A. Lane, M. Mason, C. Metcalfe: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. In: The New England journal of medicine. Band 375, Nr. 15, 13. Oktober 2016, ISSN 0028-4793, S. 1425–1437, doi:10.1056/NEJMoa1606221, PMID 27626365, PMC 5134995 (freier Volltext).
  • C. M. Yablon et al.: Complications of prostate cancer treatment: spectrum of imaging findings. In: Radiographics. Band 24, Supplement 1, Oktober 2004, S. S181–S194. doi:10.1148/rg.24si045502. PMID 15486240. (Review).
  • R. S. Kushwaha et al.: Physiologic changes of the anorectum after pelvic radiotherapy for the treatment of prostate and bladder cancer. In: Diseases of the Colon and Rectum. Band 46, Nummer 9, September 2003, S. 1182–1188, doi:10.1007/s10350-004-6712-0. PMID 12972961.
  • N. P. Mendenhall et al.: Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. In: International journal of radiation oncology, biology, physics. Band 88, Nummer 3, März 2014, S. 596–602, doi:10.1016/j.ijrobp.2013.11.007. PMID 24521677.
  • G. S. Merrick, W. M. Butler: Rectal function following permanent prostate brachytherapy. In: The West Virginia medical journal. Band 100, Nummer 1, Januar–Februar 2004, S. 18–20. PMID 15119492.
  • G. M. Duchesne et al.: Outcome, morbidity, and prognostic factors in post-prostatectomy radiotherapy: an Australian multicenter study. In: Urology. Band 61, Nummer 1, Januar 2003, S. 179–183. PMID 12559292.
  • T. E. Schultheiss, W. R. Lee, M. A. Hunt, A. L. Hanlon, R. S. Peter, G. E. Hanks: Late GI and GU complications in the treatment of prostate cancer. In: Int. J. Radiat. Oncol. Biol. Phys. Band 37, Nr. 1, Jan 1997, S. 3–11. PMID 9054871.
  • N. H. Gilinsky, D. G. Burns, G. O. Barbezat, W. Levin, H. S. Myers, I. N. Marks: The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. In: Q. J. Med. Band 52, Nr. 205, 1983, S. 40–53. PMID 6603628.
  • P. J. Prada et al.: Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients. In: Brachytherapy. Band 8, Nr. 2, 2009, S. 210–217. doi:10.1016/j.brachy.2008.11.010. PMID 19213607.
  • W. R. Noyes, C. C. Hosford, S. E. Schultz: Human collagen injections to reduce rectal dose during radiotherapy. In: Int. J. Radiat. Oncol. Biol. Phys. Band 82, Nr. 5, April 2012, S. 1918–1922. doi:10.1016/j.ijrobp.2011.02.034. PMID 21514738
  • D. Y. Song et al.: A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. In: International journal of radiation oncology, biology, physics. Band 87, Nummer 1, September 2013, S. 81–87, doi:10.1016/j.ijrobp.2012.12.019. PMID 23414766. PMC 3737267 (freier Volltext).
  • M. Pinkawa et al.: Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. In: Radiotherapy and Oncology. Band 100, Nr. 3, September 2011, S. 436–441. doi:10.1016/j.radonc.2011.09.005. PMID 21963289.
  • M. J. Zelefsky et al.: Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. In: Int. J. Radiat. Oncol. Biol. Phys. Band 71, Nr. 4, July 2008, S. 1028–1033. doi:10.1016/j.ijrobp.2007.11.066. PMID 18280056.
  • M. Ritter, J. Forman, P. Kupelian, C. Lawton, D. Petereit: Hypofractionation for prostate cancer. In: Cancer J. Band 15, Nr. 1, 2009, S. 1–6. doi:10.1097/PPO.0b013e3181976614. PMC 3039916 (freier Volltext). PMID 19197165.
  • Grace L. Lu-Yao et al.: Survival following primary androgen deprivation therapy among men with localized prostate cancer. In: JAMA. Band 300, Nr. 2, 9. Juli 2008, S. 173–181, doi:10.1001/jama.300.2.173, PMID 18612114, PMC 2645653 (freier Volltext).
  • Ian F. Tannock et al.: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. In: The New England Journal of Medicine. Band 351, Nr. 15, 7. Oktober 2004, S. 1502–1512, doi:10.1056/NEJMoa040720, PMID 15470213.
  • D. Mukherji, C. J. Pezaro, J. S. De-Bono: MDV3100 for the treatment of prostate cancer. In: Expert Opinion on Investigational Drugs. Band 21, Nummer 2, Februar 2012, S. 227–233, doi:10.1517/13543784.2012.651125. PMID 22229405.
  • F. Saad et al.: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. In: Journal of the National Cancer Institute. Band 94, Nummer 19, Oktober 2002, S. 1458–1468. PMID 12359855.
  • L. Weissbach, J. Altwein: Aktive Überwachung oder aktive Therapie beim lokalen Prostatakarzinom? In: Deutsches Ärzteblatt international. Band 106, Nummer 22, Mai 2009, S. 371–376, doi:10.3238/arztebl.2009.0371. PMID 19623304. PMC 2704359 (freier Volltext). (Review).
  • G. Bozzini et al.: Focal therapy of prostate cancer: energies and procedures. In: Urologic oncology. Band 31, Nummer 2, Februar 2013, S. 155–167, doi:10.1016/j.urolonc.2012.05.011. PMID 22795500. (Review).
  • P. A. Burch et al.: Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial. In: Prostate. 60, 2004, S. 197–204. PMID 15176049.
  • J. E. Johansson et al.: Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. In: JAMA: the journal of the American Medical Association. Band 277, Nummer 6, Februar 1997, S. 467–471. PMID 9020270. Abstract (deutsch) (Memento vom 18. Oktober 2004 im Internet Archive)
  • C. R. Porter et al.: 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. In: The Journal of urology. Band 176, Nummer 2, August 2006, S. 569–574, doi:10.1016/j.juro.2006.03.094. PMID 16813891.
  • A. W. Partin et al.: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. In: Urology. Band 58, Nummer 6, Dezember 2001, S. 843–848. PMID 11744442.
  • Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L. J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Liisa Määttänen, Hans Lilja, Louis J. Denis, Franz Recker, Alvaro Paez, Chris H. Bangma, Sigrid Carlsson, Donella Puliti, Arnauld Villers, Xavier Rebillard, Matti Hakama, Ulf-Hakan Stenman, Paula Kujala, Kimmo Taari, Gunnar Aus, Andreas Huber, Theo H. van der Kwast, Ron H. N. van Schaik, Harry J. de Koning, Sue M. Moss, Anssi Auvinen, ERSPC Investigators: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. In: The Lancet. Band 384, Nr. 9959, 6. Dezember 2014, ISSN 1474-547X, S. 2027–2035, doi:10.1016/S0140-6736(14)60525-0, PMID 25108889, PMC 4427906 (freier Volltext).
  • Jonas Hugosson, u. a.: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. In: European Urology. Band 76, Nr. 1, 1. Juli 2019, ISSN 0302-2838, S. 43–51, doi:10.1016/j.eururo.2019.02.009, PMID 30824296, PMC 7513694 (freier Volltext) – (sciencedirect.com [abgerufen am 23. Oktober 2023]).

orf.at (Global: 418th place; German: 22nd place)

ooe.orf.at

praxis-margareten.at (Global: low place; German: low place)

  • P. Grimm et al.: Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. In: BJU international. Band 109, Supplement 1, Februar 2012, S. 22–29. doi:10.1111/j.1464-410X.2011.10827.x. PMID 22239226. (Review). praxis-margareten.at (PDF, Volltext)

prostatakrebs-bps.de (Global: low place; German: low place)

magazin.prostatakrebs-bps.de

  • Verena Katzke, Rudolf Kaaks: Krebs und Ernährung. (PDF; 1,6 MB). In: Bundesverband Prostatakrebs Selbsthilfe e. V., 1/2016, S. 17–19.

prostatakrebs-bps.de

sciencedirect.com (Global: 149th place; German: 298th place)

swr.de (Global: 1,755th place; German: 114th place)

uni-luebeck.de (Global: low place; German: 6,860th place)

urologielehrbuch.de (Global: low place; German: 3,838th place)

uroweb.org (Global: low place; German: low place)

wcrf.org (Global: low place; German: low place)

web.archive.org (Global: 1st place; German: 1st place)

zdb-katalog.de (Global: 123rd place; German: 6th place)

  • Walter C. Willett, David S. Ludwig: Milk and Health. In: New England Journal of Medicine. Band 382, Nr. 7, 13. Februar 2020, ISSN 0028-4793, S. 644–654, doi:10.1056/NEJMra1903547, PMID 32053300.
  • Kazuya Mikami, Kotaro Ozasa, Tsuneharu Miki, Yoshiyuki Watanabe, Mitsuru Mori: Dairy products and the risk of developing prostate cancer: A large-scale cohort study (JACC Study) in Japan. In: Cancer Medicine. 4. Oktober 2021, ISSN 2045-7634, doi:10.1002/cam4.4233, PMID 34606688.
  • Catherine C. Applegate, Joe L. Rowles, Katherine M. Ranard, Sookyoung Jeon, John W. Erdman: Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. In: Nutrients. Band 10, Nr. 1, 4. Januar 2018, ISSN 2072-6643, doi:10.3390/nu10010040, PMID 29300347, PMC 5793268 (freier Volltext): „This hypothesis has further been supported by four previous meta-analyses of epidemiological studies, all of which showed a protective association between soy consumption and PCa …“
  • Catherine C. Applegate, Joe L. Rowles, Katherine M. Ranard, Sookyoung Jeon, John W. Erdman: Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. In: Nutrients. Band 10, Nr. 1, 4. Januar 2018, ISSN 2072-6643, doi:10.3390/nu10010040, PMID 29300347, PMC 5793268 (freier Volltext).
  • Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, Malcolm Mason, Chris Metcalfe: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. In: The New England Journal of Medicine. Band 375, Nr. 15, 13. Oktober 2016, ISSN 1533-4406, S. 1415–1424, doi:10.1056/NEJMoa1606220, PMID 27626136.
  • J. L. Donovan, F. C. Hamdy, J. A. Lane, M. Mason, C. Metcalfe: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. In: The New England journal of medicine. Band 375, Nr. 15, 13. Oktober 2016, ISSN 0028-4793, S. 1425–1437, doi:10.1056/NEJMoa1606221, PMID 27626365, PMC 5134995 (freier Volltext).
  • Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L. J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Liisa Määttänen, Hans Lilja, Louis J. Denis, Franz Recker, Alvaro Paez, Chris H. Bangma, Sigrid Carlsson, Donella Puliti, Arnauld Villers, Xavier Rebillard, Matti Hakama, Ulf-Hakan Stenman, Paula Kujala, Kimmo Taari, Gunnar Aus, Andreas Huber, Theo H. van der Kwast, Ron H. N. van Schaik, Harry J. de Koning, Sue M. Moss, Anssi Auvinen, ERSPC Investigators: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. In: The Lancet. Band 384, Nr. 9959, 6. Dezember 2014, ISSN 1474-547X, S. 2027–2035, doi:10.1016/S0140-6736(14)60525-0, PMID 25108889, PMC 4427906 (freier Volltext).
  • Jonas Hugosson, u. a.: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. In: European Urology. Band 76, Nr. 1, 1. Juli 2019, ISSN 0302-2838, S. 43–51, doi:10.1016/j.eururo.2019.02.009, PMID 30824296, PMC 7513694 (freier Volltext) – (sciencedirect.com [abgerufen am 23. Oktober 2023]).